Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangementYi Xu, Jiang F. Zhong, Kevin R. Kelly et al.|Drug Resistance Updates|2025Cited by 3